CClinicalTrials.gg
CompletedNCT03538418Updated Apr 9, 2020

Enhancing Physical Activity Levels of Frail Older People With a Wearable Activity Tracker-based Exercise Intervention

An interventional study of WAT in Frail Elderly, sponsored by The Hong Kong Polytechnic University. Completed at 1 site in Hong Kong. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2020-04-09.

Sponsored by The Hong Kong Polytechnic University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

This study aims to investigate the feasibility, acceptability, and preliminary effects of a Wearable Activity Tracker (WAT)-based exercise intervention to increase physical activity levels in frail or pre-frail older people. One group of participants will receive a WAT-based exercise intervention incorporated with the support of behavioral change techniques (BCTs) and technical issues, while the other group will receive only an exercise intervention incorporated with BCTs support.

Read the detailed description

Six community centres, which provide similar types of community care and social support services for community-dwelling older people, will be invited by a convenience method to work as collaborators in this study. Using computer-generated random numbers, a biostatistician not affiliated with this study will randomize the centres in a 1:1 ratio into either: the control or the experimental groups (WAT group).

The WAT group will receive a 3-month exercise programme plus WAT intervention which aims to strengthen the participants' motivation to develop the intention to gradually increase their physical activity levels to eventually meet the level recommended for older people by the American Heart Association (AHA). Two face-to-face sessions followed by weekly to monthly telephone sessions offering support on dealing with technical issues and BCTs will be arranged for the experimental group. The additional technical support given alongside the WAT intervention will be gradually withdrawn from the participants. Eventually, all additional measures to support the use of WATs among participants will be stopped. Participants will be left to use the WAT on their own for 3 months during the follow-up period. In addition, they will receive a weekly 45-60 minute center-based structured exercise programme for 3 months, which is designed according to the AHA's recommendations on exercise for older people.

The control group will receive another 3-month exercise programme with face-to-face, and telephone-delivered BCTs follow-up sessions, with the number and timing of all sessions similar to that in the experimental group.

02

Conditions studied

  • Frail Elderly

Keywords

  • Frailty
  • Wearable technology
  • Physical activity
  • Behaviour change
03

In context

Lead sponsor

The Hong Kong Polytechnic University is the lead sponsor of 659 studies on the registry; 250 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • community-dwelling older people aged > 65 years;
  • able to communicate in Cantonese to ensure that they understand our instructions;
  • able to walk with or without an assistive device and able to complete the Time Up and Go (TUG) test with no specific cutoff point to ensure that their mobility and balance is good enough to join the exercise training;
  • able to use a smartphone;
  • with daily walking steps less than 7000, and
  • in a pre-frail or frail state as determined using the Fried Frailty Index; including: i) having experienced an unintentional loss of 10% of body weight in the past year; ii) exhaustion: by answering 'Yes' to either 'I felt that everything I did was an effort', or 'I could not get going in the last week'; iii) a slow walk time: with an average walking speed in the lowest quintile stratified by median body height; iv) reduced grip strength: with maximal grip strength in the lowest quintile stratified by the body mass index quartile; and v) a Physical Activity Scale for Elderly-Chinese (PASE-C) score in the lowest quartile (i.e., \< 30 for men and \< 27.7 for women). The presence of 1-2 indicates pre-frailty, > 3 items indicates frailty.

Exclusion criteria

Exclusion Criteria are older people who:

  • have any physical conditions that hamper their performance of the exercise programme or use of the WAT, such as visual or hearing problems.
  • regularly engage in moderately intense exercise (such as hiking, Tai Chi) for > 3 hours per week.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    WAT group

    The WAT group will receive a 3-month WAT-based exercise training programme, which includes 12 weekly exercise training sessions (an hour each) in addition to 2 face-to-face sessions followed by weekly to monthly telephone sessions offering support on dealing with technical issues and BCTs (7 session in total). The WAT group will be left to use the WAT on their own for 3 months during the follow-up period.

    Other: WAT

  • No intervention
    Control group

    The control group will receive a 3-month exercise training programme without a WAT, which also includes 12 weekly exercise training sessions (an hour each) in addition to 7 face-to-face and telephone sessions offering support for BCTs.

Interventions

  • OtherWAT

    The WAT intervention consists of 12 weekly WAT-based exercise sessions and 7 sessions of support for BCTs and technical issues.

06

What researchers measure

Primary outcomes

  1. Frequency of using the activity tracker

    The number of days that a participant in the experimental group wears and syncs the device divided by the number of intervention days.

    Time frame: Throughout the 3-month programme

  2. Recruitment rate

    The proportion of participants who consent to join the study over the eligible participants.

    Time frame: Enrollment date

  3. Attrition rate

    The percentage of participants who withdraw from the study and their reasons for withdrawing.

    Time frame: At the end of the 3-month programme

  4. Adherence to the exercise regimen

    Exercise adherence will be assessed by the training session attendance, the participants' adherence to the desired levels of MVAP as suggested by the physical trainer and the exercise diary.

    Time frame: Throughout the 3-month programme

  5. Occurrence of adverse events at home

    Any adverse events at home will be recorded.

    Time frame: Throughout the 3-month programme

  6. Change of activity levels (total steps) measured by ActiGraph wGT3X accelerometer.

    The participants' total steps will be collected.

    Time frame: Change from Baseline Activity Level at 1 week, *1 month and * 3 month post-intervention (* only for the experimental group)

  7. Change of activity levels (activity) measured by ActiGraph wGT3X accelerometer.

    The time spent in activities of different intensity (sedentary, light, moderate and vigorous) will be collected.

    Time frame: Change from Baseline Activity Level at 1 week, *1 month and *3 month post-intervention(* only for the experimental group)

  8. Change of sleep quality (sleep time) measured by ActiGraph wGT3X accelerometer.

    The participant's total sleep time will be collected.

    Time frame: Change from Baseline Activity Level at 1 week, *1 month and *3 month post-intervention. (* only for the experimental group)

  9. Change of sleep quality (wake after sleep onset) measured by ActiGraph wGT3X accelerometer.

    The frequency of wake after sleep onset of the participant will be collected.

    Time frame: Change from Baseline Activity Level at 1 week, *1 month and *3 month post-intervention.(* only for the experimental group)

Secondary outcomes

  1. Activity levels (total steps) assessed by activity monitor (Fitbit)

    The total steps per week of an individual will be collected.

    Time frame: Throughout the 3-month programme

  2. Activity levels (total walking distance) assessed by activity monitor (Fitbit)

    The total walking distance per week of an individual will be collected.

    Time frame: Throughout the 3-month programme

  3. Activity levels (time spent in different heart rate zones) assessed by activity monitor (Fitbit)

    The time spent in different heart rate zones of an individual will be collected.

    Time frame: Throughout the 3-month programme

  4. Participants' lower-limb strength will be assessed using the 30-second chair stand test

    Participants will be asked to stand up and sit down as many as they can within 30 seconds on a standard chair. The total number of standing up from a chair will be counted. More number indicates better lower-limb strength

    Time frame: Baseline, at 1 week, *1 month and* 3 month post-intervention (* only for the experimental group)

  5. Participants' upper-limb strength will be assessed using a handheld Jamar Hydraulic Hand Dynamometer

    It will be measured by handheld Jamar Hydraulic Hand Dynamometer with kilogram (kg). Greater force in kg indicates better upper-limb strength

    Time frame: Baseline, at 1 week, *1 month and *3 month post-intervention (* only for the experimental group)

  6. Participants' functional mobility will be measured by the timed-up-and-go-test

    Record the time in second that participants complete the timed up and go test to indicate their functional mobility

    Time frame: Baseline, at 1 week, *1 month and *3 month post-intervention

  7. Participants' gait speed will be measured by the 2 minutes walk test

    Record the time in second that participants complete the 2 minutes walk test to indicate the their gait speed.

    Time frame: Baseline, at 1 week, 1 month and 3 month post-intervention (* only for the experimental group)

  8. Participants' exercise self-efficacy will be measured using Chinese Self-Efficacy for Exercise (CSEE) scale

    The CSEE scale contains of 9 items. Each item is rated on 11-point Liker scale from 0 = no confidence to 10 = full of confidence. All item scores are summed to get the total score which ranges from 0 to 90 with a higher score indicates higher exercise self-efficacy

    Time frame: Baseline, at 1 week, *1 month and *3 month post-intervention (* only for the experimental group)

  9. Participants' frailty level will be assessed using Fried Frailty Index (FFI)

    Fried Frailty Index includes: i) an unintentional loss of 10% of body weight in the past year; ii) exhaustion: by answering 'Yes' to either 'I felt that everything I did was an effort', or 'I could not get going in the last week'; iii) a slow walk time: with an average walking speed in the lowest quintile stratified by median body height; iv) reduced handgrip strength: with maximal grip strength in the lowest quintile stratified by body mass index quartile; and v) the Physical Activity Scale for the Elderly-Chinese (PASE-C) score in the lowest quintile (i.e., \< 30 for men and \< 27.7 for women).

    Time frame: Baseline, at 1 week, *1 month and *3 month post-intervention (* only for the experimental group)

  10. Participants' self-reported sedentary behavioral and physical activity will be assessed using Global Physical Activity Questionnaire-Chinese version (C-GPAQ)

    The C-PAQ comprises 16 questions designed to estimate an individual's self-perceived level of physical activity in three domains (occupational, transport-related and discretionary or leisure time).

    Time frame: Baseline, at 1 week, *1 month and *3 month post-intervention (* only for the experimental group)

  11. Participants' motivation to engage in physical activity using of the Behavioral Regulation in Exercise Questionnaire-2 (C-BREQ-2)

    C-BREQ-2 is a 19-item questionnaire assessing five dimensions: amotivation, external regulation, introjected regulation, identified regulation, and intrinsic regulation. Each item is rated on a 5-point scale ranging from 0 = "not true for me" to 4 = "very true for me", with higher scores indicative of higher motivation.

    Time frame: Baseline, at 1 week, *1 month and *3 month post-intervention (* only for the experimental group)

07

Study locations

1 site
  • The Hong Kong Polytechnic Universtiy
    Hong Kong, Hong Kong
08

References and documents

Study documents

  • Informed consent form · Apr 13, 2018
  • Statistical analysis plan · Apr 13, 2018
  • Study protocol · Apr 13, 2018

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03538418
Lead sponsor
The Hong Kong Polytechnic University
Responsible party
Dr. Justina Liu Yat Wa (Associate Professor, The Hong Kong Polytechnic University) — Principal investigator
First posted
May 29, 2018
Start date
Jun 1, 2018
Primary completion
Mar 31, 2020
Completion
Mar 31, 2020
Last update
Apr 9, 2020

Study contacts

Justina LIU, Dr.
principal investigator · The Hong Kong Polytechnic University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion